Rerate in progress8 Nov 2018 19:23
“The acceptance by EUNCL is a strong indication of the exciting potential for our Nuvec system and as the costs of these studies will be met within the EUNCL grant, it significantly reduces the cost to the company of our regulatory development programme.”